Watch CBS News
Georgia has become the latest state to temporarily shut down a vaccination site after multiple people reported adverse reactions to the Johnson and Johnson COVID-19 vaccine. Pfizer has asked the FDA to expand emergency use of its COVID-19 vaccine to adolescents, as cases spike in children. CBS News researcher Max Bayer joins CBSN to discuss.
Pfizer wants to extend its COVID-19 vaccine to those as young as 12 years old and has asked the FDA for authorization to do that.
Multiple companies are developing vaccine passport apps as proof of immunization against the coronavirus, but whether they can be legally required is up for debate. Adriana Diaz has more.
Only a handful of people who got the drugmakers' vaccine contracted coronavirus, according to the latest trial.
The results are seen as a step toward possibly beginning shots in that age group before they head back to school in the fall.
In a study of more than 2,200 kids between 12 and 15 years old, Pfizer found that its COVID-19 vaccine is fully effective and safe. Dr. Susannah Hills spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about what this study means for school reopenings and herd immunity in the U.S.
Pfizer announced it has started testing its COVID-19 vaccine on children under 12 years old. Dr. Bob Lahita spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about what researchers are looking for. He also explained how some people experience swollen lymph nodes as a side-effect from vaccination, which could be mistaken for a sign of breast cancer, and what you need to know before you go in for a mammogram.
President Biden has set a new goal of administering 200 million coronavirus vaccine doses by the end of April. It comes as at least 20 states are reporting a rise in new cases. As CBS News' Mola Lenghi reports, officials say the variant first found in the U.K. may be to blame. Then, Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital, joins CBSN's Lana Zak with his insight.
Scientists behind an Oxford University-led trial in the U.K. say the results could help address both vaccine shortages, and worrying coronavirus variants.
Vaccine distribution efforts in the U.S. are ramping up. President Biden has promised enough doses for all adults by the end of May. Part of the plan to reach that goal is to make the shots available at more than 20,000 pharmacies nationwide. But access to physical pharmacies is not an option for many people, particularly those who live in rural areas. Dr. Michael Hogue, dean of the School of Pharmacy at Loma Linda University and president of the American Pharmacists Association, joined CBSN's Elaine Quijano to discuss.
Countries across Europe are back to administering the AstraZeneca vaccine after questions were raised about its safety. Chris Livesay reports.
President Biden is on track to beat his goal of 100 million COVID shots administered in his first 100 days. But cases are surging in more than a dozen states. Nikki Battiste reports.
A partnership with the government allowed Americans to receive the vaccine for free, but, according to Pfizer, does not mean the federal government helped fund its creation.
Facebook Chief Product Officer Chris Cox explains how the tech firm will amplify authoritative information about coronavirus vaccines.
Ahead of the anticipated distribution of the two-dose coronavirus vaccines from Moderna and Pfizer, medical experts are stressing the importance of getting the shots, and they say patients shouldn't be deterred by the possibility of minor side effects. Dr. Dara Kass joins CBSN to discuss the latest.
In his first prime-time address since taking office, President Biden announced he is directing states to make COVID vaccines available to everyone 18 and older by May 1. He also said the U.S. could see a return to some sort of normalcy by the Fourth of July. Dr. Bob Lahita spoke with CBSN's Anne-Marie Green and Vladimir Duthiers about the president's address and concerns about the variants that continue to spread.
More states are easing coronavirus restrictions despite health experts warning that moving too quickly could risk another surge in infections. Texas on Wednesday will become the latest state to lift its mask mandates and allow business to return to normal operations. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joins CBSN to discuss the latest.
New CDC guidelines are a "first step" toward a normal life. They say people who have been fully vaccinated against COVID-19 can gather in small groups together indoors without masks or social distancing. And those fully vaccinated can visit unvaccinated people who are from one household and low risk for severe COVID symptoms. Dr. David Agus joins "CBS This Morning" to explain the guidelines.
While more than 60 million vaccine doses have been administered in the U.S., the country of Zambia has not yet received any vaccines. According to international vaccine equity initiative COVAX, unchecked infection anywhere in the world may give rise to further mutations that threaten health globally. CIDRZ lead laboratory scientist Michelo Simuyandi joins CBSN AM on the phone from Lusaka, Zambia, to talk about the situation in Sub-Saharan Africa.
The FDA is reviewing the Johnson & Johnson COVID-19 vaccine and it could get emergency authorization by the end of the week. Unlike the Moderna and Pfizer vaccines, this one only requires only one shot. Josh Michaud, associate director for global health policy at the Kaiser Family Foundation, joins CBSN AM to discuss the significance.
To help ramp up vaccination efforts, the pharmaceutical company Merck has agreed to help mass-produce Johnson and Johnson's single-dose coronavirus vaccine. President Biden now says there will be enough doses for every adult in the country by the end of May. CBS News correspondent Janet Shamlian reports from Houston, and Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN's Elaine Quijano to discuss the latest.
The Biden administration is marking a new milestone in the fight against the coronavirus pandemic. The U.S. has administered 50 million of its promised 100 million vaccine doses in just five weeks. This comes as homegrown variants cause alarm on both coasts on the country. Dr. Richard Besser, the president and CEO of the Robert Wood Johnson Foundation and the former acting director of the CDC, joins CBSN to discuss the latest.
The FDA could issue emergency approval of Johnson and Johnson's single-dose COVID-19 vaccine as soon as Friday. Meanwhile there's growing evidence of the effectiveness of Pfizer's vaccine in the real world. Dr. Leo Nissola joins CBSN with more on the differences between the single and multi-dose vaccines and efforts to convince uncertain Americans to take them.
Pfizer and Moderna told lawmakers 140 million more vaccine doses will be available for shipment by the end of next month. Dr. Teresa Amato, the director of emergency medicine at Long Island Jewish Forest Hills, joins CBSN with more on how to prevent another surge.
CBSN's Tanya Rivero gets answers to more of your questions regarding the COVID-19 vaccines from Dr. Anthony Fauci.
